New Jersey investigates Amgen's Enbrel activity

01/17/2008 | NYTimes.com · Seattle Times, The

The New Jersey attorney general has asked Amgen to submit documentation on the marketing push and prescription activity for its best-selling psoriasis treatment, Enbrel, following claims of unethical marketing by two former sales representatives. Amgen said it would cooperate with the investigation and said the accusations have no merit.

View Full Article in:

NYTimes.com · Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY